Our Pediatrician, Dr. Luca Molinari, explains what the recent meningococcal disease cases in Kent mean for families and whether children’s vaccination schedules need to change.
Following the recent reports of invasive meningococcal disease in Kent, many families have been asking whether this affects their child’s vaccination schedule. Cases like these are uncommon, and public health teams act quickly to identify close contacts and offer antibiotics and, where appropriate, vaccination to those directly exposed. For the wider community, the overall risk remains low, and current national recommendations have not changed.
Read the official BBC article here
In the UK, babies are routinely offered the MenB vaccine at 8 weeks, 12 weeks and 1 year. This schedule is designed to protect infants during the period when they are most at risk of MenB disease.
Teenagers are routinely offered the Meningococcal vaccine at school in Year 9, usually at 13 to 14 years of age, and anyone who missed it remains eligible for catch-up vaccination up to their 25th birthday. This vaccine helps protect against meningococcal groups A, C, W and Y.
Outside these routine groups, meningitis vaccines on the NHS are generally offered only to people with specific medical risk factors or in defined exposure settings. Families who would like to explore additional protection can also discuss private Meningococcal vaccination with their doctor. This is best considered on an individual basis, depending on age, health background and specific concerns.
The key message for parents is to keep their child’s routine vaccinations up to date. The recent Kent cases are understandably concerning, but at present they do not change the national vaccination schedule for the wider public. If you are unsure whether your child is fully protected, speaking to your GP or a trusted clinician is the best next step.